Şener MU, Çiçek T, Öztürk A. Highlights of clinical and laboratory parameters among severe COVID-19 patients treated with tocilizumab: a retrospective observational study. Sao Paulo Med J [Internet]. 2022 Sep. 1 [cited 2025 Mar. 14];140(5):627-35. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/988